Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2010
10/05/2010US7807873 Seed specific USP promoters for expressing genes in plants
10/05/2010US7807872 Inhibitor of cyclin-dependent kinase (ICK) nucleic acid and polypeptide molecules, useful as modulating agents in regulating cell cycle progression in plants
10/05/2010US7807871 Using vector transformation of sucrose 1-fructosyl transferases (1-SST) and/or fructan 1-fructosyl transferases (1-FFT) genes to generate transgenic plants with an enhanced capacity to store sucrose and fructan
10/05/2010US7807870 Using transgenic plants as bioreactors for synthesis of hemoglobin
10/05/2010US7807869 Transgenic plants expressing gastrodianin antifungal proteins; enhancing crop resistance to funnngal assualt; improved exogenous gene expression
10/05/2010US7807868 Mobilization of viral genomes from T-DNA using site-specific recombination systems
10/05/2010US7807867 Expression vector comprising nucleotide sequences coding plant growth regulator; enhancing cell division and bud formation; overcoming dormancy of axillary buds; preventing aging and promoting enlargement of fruit
10/05/2010US7807866 Method and compositions for the production of transgenic plants
10/05/2010US7807865 Transgene assay using stable agrobacterium rhizogenes transformation
10/05/2010US7807863 Transgenic bovine having reduced prion protein activity and uses thereof
10/05/2010US7807862 Transgenic bovine comprising human growth hormone in its serum and methods of making
10/05/2010US7807849 Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
10/05/2010US7807822 Purification of plasmid nucleotide sequences from bacterial cells; obtain cells, lyse, precipatate, centrifuge precipitate mixture, expose to ion exchange column, recover nucleotide sequences
10/05/2010US7807821 Method for the synthesis of nucleic acid without protecting base moiety
10/05/2010US7807820 Short interference RNA duplexes, when introduced into mammalian cells in culture, perform sequence-specific inhibition of target mRNA without inducing an interferon response; specific gene silencing
10/05/2010US7807819 siRNA targeting survivin
10/05/2010US7807818 Reverse-sense nucleotide sequences for use in treatment of ulcerative colitis, crohn's and/or inflammatory bowel disease
10/05/2010US7807816 Antisense oligonucleotides for inducing exon skipping and methods of use thereof
10/05/2010US7807815 nucleic acid-lipid particles comprising short intefering sequences with mismatch motif, and 1,2-DiLinoleyloxy-N,N-dimethylaminopropane (DLinDMA) or 1,2-Dilinolenyloxy-N,N-dimethylaminopropane (DLenDMA), for use in silencing target gene sequences
10/05/2010US7807814 Compositions and methods for combined therapy of disease
10/05/2010US7807812 Actin regulatory elements for use in plants
10/05/2010US7807811 Actin regulatory elements for use in plants
10/05/2010US7807809 Molecular characterization of chromosome translocation t(11;18)(q21;q21) and its correlation to carcinogenesis
10/05/2010US7807808 Bacteria with increased levels of protein secretion, nucleotide sequences coding for a SecA protein with increased levels of protein secretion, and method for producing proteins
10/05/2010US7807806 Composition comprising nucleic acid which forms cleavable nucleic acid structure on specific target sequences in a site-specific manner
10/05/2010US7807805 isolated nucleic acid encoding an immunogenic peptide recognized by T lymphocytes; host cell transfected with the recombinant expression vector encoding an immunogenic protein; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
10/05/2010US7807804 Expression vector comprising gene constructs with deleted sequences; ehnancing heterologous gene expression
10/05/2010US7807801 Method of inhibition of flavivirus to prevent and cure viral diseases by administering nucleotides
10/05/2010US7807796 ULBP antibodies
10/05/2010US7807795 Antibodies to osteoprotegerin binding proteins
10/05/2010US7807787 NELL-1 (Nel-like molecule-1) polypeptide for use in induction and treatment of bone formation and disorders
10/05/2010US7807786 Activation antigen expressed on B-cells for treating conditions associated with aberrant or increased T-cell proliferation
10/05/2010US7807783 Fas associating protein with a novel death domain(FADD) for use in treatment and prevention programmed cell death associated disorders
10/05/2010US7807782 Using targeted reactions between proline and adapter segments as tool in generation of preferential fusion proteins; directed protein evolution
10/05/2010US7807780 Multi-component biological transport systems
10/05/2010US7807778 Cysteine-containing peptide tag for site-specific conjugation of proteins
10/05/2010US7807652 Antisense agents for use in treatment of diabetes and controlling blood lipid levels; gene expression inhibition; genes involved in glucose metabolism are glucose-6-phosphatase and glycogen synthase;steatohepatitis; decreasing hepatic triglyceride levels
10/05/2010US7807651 Methods and materials for pain management
10/05/2010US7807649 Antisense oligonucleotides; diabetes, rhabdomyosarcoma; screening for the modulators
10/05/2010US7807647 administering an antigene oligonucleotide that hybridizes under physiological conditions to the promoter region of a bcl-2 gene; anticarcinogenic agents for melanomas, pancreatic, colon, breast, bladder, lung, leukemia, prostate, lymphoma, and ovarian cancers; docetaxel
10/05/2010US7807638 Amino acid substitution in position 36; brain bleeding, hemorrhage, trauma or injury; genetic engineering and expression; biodrugs, anticoagulants
10/05/2010US7807627 treating bone disorders related to bone, cartilage, tendon or tooth formation; recombinant BMP protein having a heparin binding site; expressing a BMP protein in a bacterial E. Coli host; low immunogenicity
10/05/2010US7807617 Peptide inhibitors of toxins derived from LL-37
10/05/2010US7807460 Plasmid regulated by heat-shock sigma factor for use as gene transfer tool in genetic engineering; improved/enhanced exogenous transcription
10/05/2010US7807457 Recombinant viral and non-viral vectors containing the human urokinase plasminogen activator gene and its utilization in the treatment of various types of hepatic, renal, pulmonary, pancreatic and cardiac fibrosis and hypertrophic scars
10/05/2010US7807456 Recombinant attenuated Clostridium organisms and vaccine
10/05/2010US7807455 Generating viral replicon having an increased replication activity in a Huh7 cells using variant viral coding sequences; prevention and treatment of liver inflammation, infection and failure
10/05/2010US7807449 Nucleic acid amplification reaction station for disposable test devices
10/05/2010US7807444 Prokaryotic recombinant host cell for use as bioreactor; improved heteroloogous gene expression
10/05/2010US7807443 Microorganisms providing novel gene products forming or decomposing polyamino acids
10/05/2010US7807442 PUFA polyketide synthase systems and uses thereof
10/05/2010US7807441 Nucleotide sequences which code protein that induces cytotoxic T-lymphocyte immunity against weak selfproteins; antitumor agents
10/05/2010US7807438 Vessicular composition comprising hepatitis C virus RNA sequences for use in designing drugs for treatment and prevention of viral infection
10/05/2010US7807436 Recombinant host for producing L-asparaginase II
10/05/2010US7807434 Detergent composition comprising enhanced glucanase for use in textile treatment and enhancing cleaning performance
10/05/2010US7807433 Heat resistant hydrolase for use in food processing, pharmaceuticals, textile treatment, detergent and baking industries
10/05/2010US7807431 Detection of nucleic acid differences using combined endonuclease cleavage and ligation reactions
10/05/2010US7807430 Polypeptide of 250-419 contiguous amino acids of SEQ ID NO:1, where tyrosine 216 is phosphorylated and the polypeptide will crystallize; biological activity consisting of binding a GSK3 inhibitor and kinase activity; antidiabetic agents; Alzeimer's disease; antiinflammation agents; biological screening
10/05/2010US7807426 Processes for producing optically active 1-substituted 2-methylpyrrolidine
10/05/2010US7807425 Reacting a glyceride, an acetylated saccharide or other ester such a mono- or diester of a glycol with a source of peroxygen in the presence of an enzyme of the CE-7 family of carbohydrate esterases, including cephalosporin acetyl hydrolases and acetyl xylan esterases
10/05/2010US7807424 Chalcone synthase with modified active sites for improving plant defenses and pigment production
10/05/2010US7807421 Process for production of biopterin compound
10/05/2010US7807418 Method for producing hybrid polyketide synthases
10/05/2010US7807417 Ecdysone receptor-based inducible gene expression system
10/05/2010US7807416 Antibodies and methods for generating genetically altered antibodies with enhanced effector function
10/05/2010US7807414 Anti-IL-23 antibodies, compositions, methods and uses
10/05/2010US7807413 making modified human Interleukin-8 (IL-8) protein; inhibition of the interaction of chemokines and their high-affinity receptors on leukocytes and methods for the therapeutic treatment of inflammatory diseases; glycosaminoglycan-binding proteins (GAG)
10/05/2010US7807412 Using platelete derived growth fator as tool in detection of modulators for prevention and treatment of cell proliferative disorders
10/05/2010US7807409 recombinant production of a heterologous polypeptide in a eukaryotic host cell by providing a eukaryotic host cell comprising an expression plasmid with a 5' to 3' direction, a promoter, nucleic acid encoding an immunoglobulin fragment, and a 3' untranslated region comprising a polyadenylation signal
10/05/2010US7807408 Directed evolution of proteins
10/05/2010US7807391 target substance capturing body comprising a substrate and a protein utilizing an anti-gold antibody and a gold-binding side which is a part of the anti-gold antibody; used for the detection of a target substance
10/05/2010US7807390 G-protein coupled receptor ligands and methods
10/05/2010US7807384 Drug screening; identifying a candidate agent that inhibits the binding of low density lipoprotein binding protein-2 (LBP-2) to an LBP-2 binding molecule
10/05/2010US7807371 Methods of selecting dopaminergic neuron proliferative progenitor cells using Lrp4/Corin markers
10/05/2010US7807357 for detecting the presence of the transgene/genomic insertion region; for transgenic glyphosate tolerance; genetic engineering
10/05/2010US7807355 drug screening; identifying a therapeutic for decreasing intraocular pressure raised due to frizzled related protein (FRP) overexpression; contacting a trabecular meshwork cell expressing a Wnt pathway component or a frizzled related protein gene product with a test compound
10/05/2010US7807353 hypoxanthine-guanine phosphoribosyltransferase gene; measuring a difference in levels of expression of a desired gene in two or more kinds of test samples
10/05/2010US7807352 Using microarray comprising immobolized biopolymers which utilizes universal detection elements as tool for identifying preferential compounds
10/05/2010US7807181 Genetic engineered mutants lipid
10/05/2010US7807179 Reoviridae virus is conjugated to a hydroxylated hydrocarbon or a polycationic polymer to reduce the clearance and immunogenicity; antiproliferative disorders
10/05/2010US7807177 Segment of glycosylation-deficient HGFalpha-chain
10/05/2010US7807176 Polypeptide promoting vascular endothelial cell growth
10/05/2010US7807174 Class of therapeutic protein based molecules
10/05/2010US7807157 Monoclonal antibodies and use thereof
10/05/2010US7807151 identifying a mammalian subject having an infection with said pathogenic Clostridium bacterium resistant to antibiotic, orally administering a therapeutically-effective concentration of Bacillus coagulans bacteria
10/05/2010US7807147 Tumor therapy with high affinity laminin receptor-targeted vectors
10/05/2010US7807145 Method of inducing neuronal production in the brain and spinal cord
10/05/2010CA2587548C Method for determining genotoxicity
10/05/2010CA2578138C Production of tnfr-ig fusion protein
10/05/2010CA2506803C Functional domain and associated molecule of dock2 essentially required in lymphocyte migration
10/05/2010CA2428662C Small acid-soluble spore protein and uses thereof
10/05/2010CA2400049C Rna polymerase mutants with increased thermostability
10/05/2010CA2393479C Process for the scaleable purification of plasmid dna
10/05/2010CA2389533C Methods and compositions for detection of mycobacterium avium complex species
10/05/2010CA2381438C Commercial production of chymosin in plants
10/05/2010CA2298438C Synthetic antigen for the detection of antibodies immunoreactive with hiv virus
10/05/2010CA2259368C Efficient nucleus transfer with foetal fibroblasts
10/05/2010CA2157219C Process for purifying recombinant human serum albumin
10/05/2010CA2086325C Ligand for cd28 receptor on b cells and methods
09/2010
09/30/2010WO2010111707A1 Variant isoprenoid producing enzymes and uses thereof
1 ... 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 ... 4023